Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2<i>H</i>,8<i>H</i>-pyrano[2,3-<i>f</i>]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease
作者:Jeelan Basha Shaik、Bhagath Kumar Palaka、Mohan Penumala、Siddhartha Eadlapalli、Manidhar Darla Mark、Dinakara Rao Ampasala、Ramakrishna Vadde、Damu Amooru Gangaiah
DOI:10.1111/cbdd.12732
日期:2016.7
approach should therefore address more than one target. In line with this modern paradigm, a series of 8‐imino‐2‐oxo‐2H,8H‐pyrano[2,3‐f]chromene analogs (4a–q) were synthesized and evaluated for their multitarget‐directed activity on acetylcholinesterase, butyrylcholinesterase (BuChE), 2,2’‐azino‐bis(3‐ethylbenzthiazoline‐6‐sulfonic acid) (ABTS) radical, and amyloid‐β peptide (Aβ) specific targets for Alzheimer's
阿尔茨海默氏病的发作和发展与多种复杂生理过程的失调有关,因此成功的治疗方法应解决多个目标。根据这种现代范式,合成了一系列8-亚氨基-2-氧代-2 H,8 H-吡喃[2,3- f ]色烯类似物(4a – q)并评估了它们在多靶点上的活性。乙酰胆碱酯酶,丁酰胆碱酯酶(BuChE的),2,2'-连氮基-双(3-乙基苯并噻唑-6-磺酸)(ABTS)基团,和淀粉样蛋白β肽(A β)阿尔茨海默氏病治疗的特定目标。大多数合成的化合物在低n m浓度下表现出显着的乙酰胆碱酯酶抑制活性,并具有良好的ABTS自由基清除活性,但是,没有BuChE抑制活性的证据。其中,3-溴苄酰胺衍生物4m表现出最好的乙酰胆碱酯酶抑制活性,IC 50值为13±1.4 n m,是参比药物加兰他敏的51倍。动力学和分子对接研究表明4m是混合型抑制剂,同时与乙酰胆碱酯酶的催化活性和外围阴离子位点结合。五种化合物4e,4f,4g,4j和4k的抗氧化活性比trolox高1